Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
PetMeds® Adopts Limited Duration Shareholder Rights Plan
-
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA
-
Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations
-
Kane Biotech Announces $3,000,000 Private Placement Offering
-
Vimeo Appoints Ryan Weeks as Chief Information Security Officer
-
SIMPPLE Ltd. Announces Distribution Partnership with Elite VDP as part of its Geographical Expansion into Vietnam
-
Enlivex Announces Positive Interim Efficacy Data from Allocetra Trial in Patients with Moderate to Severe Knee Osteoarthritis
-
Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor Imaging
-
YY Group Holding Launches YY Smart Tech to Drive Technological Innovation and Efficiency
-
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
-
Giftify, Inc. to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
-
Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma
-
MARA Acquires Wind Farm
-
GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR
-
Heritage Distilling Co. Expands into Colorado with Innermountain Distributing
-
Automated Room Controls Inc. Secures Key Certifications and Advances to Full Production
-
Blockchain Intelligence Group Launches TokenEyes - First of its kind APP, Providing Crypto Investors / Traders with Counterparty Risk Detection & Monitoring
-
Amaero Secures Long-Term Supply Agreement for U.S.-Melt Titanium Bar
-
Adeia Enters into Multi-Year IP License Agreement with Amazon
-
Dentsply Sirona to Participate in the 7th Annual Evercore ISI HealthCONx Conference
-
FORTNA Announces Strategic Global Partnerships with Packsize and Sitma
-
ACG Announces Results of Annual General Meeting of Shareholders
-
Qlik Introduces Enhanced Integrations with SAP, Databricks, and Snowflake to Drive Greater AI Value Creation
-
ECD Automotive Design Enters Into a Strategic Relationship with One Drivers Club for First Retail Launch, Bringing a Unique Design Center Experience to West Palm Beach
-
Orion Secures Major New Account in Turnkey LED Lighting Retrofit Projects for Leading Nationwide Building Products Distributor
-
Form 8.3 - Volex plc - Octopus Investments
-
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
ManTech Wins $269 Million Contract for Information Warfare Solutions
-
Palisade Bio Announces Preliminary Data from Phase 1 Clinical Study of PALI-2108 for the Treatment of Moderate-to-Severe Ulcerative Colitis Appears to be Safe and Well Tolerated in Treated Subjects
-
Sree Koneru, PhD Joins the Board of Directors of BioElectronics Corporation
-
21.co Announces Plans for New Operating Structure; 21Shares and 21.co Technologies to Become Separate Entities
-
NEO Battery Materials Announces Director Resignation and Updates to Upcoming Corporate Webinar
-
Alliance Witan PLC - Net Asset Value
-
Form 8.3 - Aviva plc
-
Sono Group N.V. to Present at NobleCon20 on December 4, 2024
-
Greenridge Exploration Announces Flow Through Financing
-
Form 8.3 - Direct Line Insurance Group plc
-
Form 8.3 - Loungers Plc
-
Seneca Polytechnic named as a Greater Toronto’s Top Employer for the 16th time
-
Know Rare Launches HealthStoryAI App for People Living with Rare Disease
-
Elevar Therapeutics and Relay Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
-
Relay Therapeutics and Elevar Therapeutics Announce Exclusive Global Licensing Agreement for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma and Other Solid Tumors
-
Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
-
OSS Announces Follow-On Order and Design Win from a Leading Defense Contractor in Asia for an Autonomous Maritime Application
-
PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET
-
ManTech Wins $715 Million Marine Corps Warfighting Lab Contract
-
Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024
-
Vortex Energy Completes High-Resolution UAV Magnetic Survey at the North Block of the Robinsons River Salt Project
-
Enphase Energy Unveils Busbar Power Control to Significantly Reduce Main Electrical Panel Upgrades
